These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20005982)

  • 1. Adalimumab level in breast milk of a nursing mother.
    Ben-Horin S; Yavzori M; Katz L; Picard O; Fudim E; Chowers Y; Lang A
    Clin Gastroenterol Hepatol; 2010 May; 8(5):475-6. PubMed ID: 20005982
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of infliximab in breast milk of nursing mothers with inflammatory bowel disease.
    Ben-Horin S; Yavzori M; Kopylov U; Picard O; Fudim E; Eliakim R; Chowers Y; Lang A
    J Crohns Colitis; 2011 Dec; 5(6):555-8. PubMed ID: 22115374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of infliximab in infants and breast milk from nursing mothers receiving therapy for Crohn's disease before and after delivery.
    Kane S; Ford J; Cohen R; Wagner C
    J Clin Gastroenterol; 2009 Aug; 43(7):613-6. PubMed ID: 19142167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infliximab concentrations in the milk of nursing mothers with inflammatory bowel disease.
    Grosen A; Julsgaard M; Kelsen J; Christensen LA
    J Crohns Colitis; 2014 Feb; 8(2):175-6. PubMed ID: 24090905
    [No Abstract]   [Full Text] [Related]  

  • 5. Duodenal Crohn's disease successfully treated with adalimumab.
    Tursi A
    Endoscopy; 2011; 43 Suppl 2 UCTN():E22. PubMed ID: 21271523
    [No Abstract]   [Full Text] [Related]  

  • 6. Distal esophageal involvement in Crohn disease: short treatment with adalimumab.
    Musto D; Martorelli L; Cirillo A; Selvaggi F; Esposito P; Russo MI; Riegler G
    Endoscopy; 2010; 42 Suppl 2():E299. PubMed ID: 21113880
    [No Abstract]   [Full Text] [Related]  

  • 7. Oropharyngeal and proximal esophageal involvement during adalimumab treatment of Crohn disease.
    Nguyen KD; Alexis R; Schwarz SM
    J Pediatr Gastroenterol Nutr; 2010 Feb; 50(2):225-6. PubMed ID: 19841594
    [No Abstract]   [Full Text] [Related]  

  • 8. [Recommendations for patients with Crohn's disease starting treatment with adalimumab: a rapid guide].
    Cabriada JL; García Sánchez V; Gomollón F; Hinojosa J; López San Román A; Mendoza JL; Mínguez M; Ricart E; Saro C
    Gastroenterol Hepatol; 2008 Dec; 31(10):693-7. PubMed ID: 19174086
    [No Abstract]   [Full Text] [Related]  

  • 9. [The use of adalimumab in severe fistulising Crohn's disease].
    Bang UC; Nielsen AM
    Ugeskr Laeger; 2008 Jun; 170(25):2256. PubMed ID: 18565318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First case report of adalimumab-induced psoriasis in Crohn's disease.
    Harris MD; Richards R
    Am J Gastroenterol; 2009 Mar; 104(3):792-3. PubMed ID: 19262532
    [No Abstract]   [Full Text] [Related]  

  • 11. Cutaneous Crohn's disease presenting as genital warts: successful treatment with adalimumab.
    Lestre S; Ramos J; João A; Serrão V
    Eur J Dermatol; 2010; 20(4):504-5. PubMed ID: 20507839
    [No Abstract]   [Full Text] [Related]  

  • 12. Adalimumab induces and maintains remission in severe, resistant paediatric Crohn disease.
    Hadziselimovic F
    J Pediatr Gastroenterol Nutr; 2008 Feb; 46(2):208-11. PubMed ID: 18223382
    [No Abstract]   [Full Text] [Related]  

  • 13. Adalimumab for recurrent orbital myositis in Crohn's disease: report of a case with a 3-year follow-up.
    Hernández-Garfella ML; Gracia-García A; Cervera-Taulet E; García-Villanueva C; Montero-Hernández J
    J Crohns Colitis; 2011 Jun; 5(3):265-6. PubMed ID: 21575896
    [No Abstract]   [Full Text] [Related]  

  • 14. [Anti-TNF agents, the class of drugs that promotes treatment for Crohn disease].
    Michetti P
    Rev Med Suisse; 2008 Jan; 4(141):187-8. PubMed ID: 18335883
    [No Abstract]   [Full Text] [Related]  

  • 15. [Adalimumab therapy in Crohn's disdease].
    Baryshnikov EN; Lazebnik LB; Parfenov AI
    Eksp Klin Gastroenterol; 2009; (5):92-8. PubMed ID: 20205331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of the nephrotic syndrome during treatment of Crohn's disease with adalimumab.
    Gupta A; Pendyala P; Arora P; Sitrin MD
    J Clin Gastroenterol; 2011 Mar; 45(3):e30-3. PubMed ID: 20975576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adalimumab for the treatment of Crohn's disease - consensus paper of the Working Group "chronic inflammatory bowel diseases" of the Austrian Society for Gastroenterology and Hepatology].
    Reinisch W; Haas T; Kaser A; Petritsch W; Vogelsang H; Feichtenschlager T; Novacek G; Siebert F; Tilg H; Knoflach P
    Z Gastroenterol; 2009 Apr; 47(4):372-80. PubMed ID: 19358065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of adalimumab in pediatric patients with Crohn disease.
    Wyneski MJ; Green A; Kay M; Wyllie R; Mahajan L
    J Pediatr Gastroenterol Nutr; 2008 Jul; 47(1):19-25. PubMed ID: 18607264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angioedema occurring in pediatric patients with Crohn disease treated with adalimumab.
    Adamiak T; Stephens M; Werlin SL
    J Pediatr Gastroenterol Nutr; 2010 Aug; 51(2):223-5. PubMed ID: 20410840
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug-induced lupus associated with infliximab and adalimumab in an adolescent with Crohn disease.
    Zella GC; Weinblatt ME; Winter HS
    J Pediatr Gastroenterol Nutr; 2009 Sep; 49(3):355-8. PubMed ID: 19516196
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.